glp 1 and schizophrenia Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric neurodevelopmental conditions: evidence from a drug target Mendelian randomization | BMC Psychiatry Potential Role of Glucagon-like Peptide-1
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23























:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)





